Imaxio, Sanofi deal

Sanofi's Merial Ltd. animal health division will conduct an internal review of Imaxio's IMX313 technology for 12-18 months to develop an animal health vaccine. Merial will then have an option to sign a license deal. Details regarding the vaccine candidate and the financial terms are not disclosed. ...